We are sorry, but NCBI web applications do not support your browser and may not function properly. More information

Results: 3

1.
FIGURE 2

FIGURE 2. From: CCR5 Expression is Elevated on Endocervical CD4+ T-Cells in Healthy Postmenopausal Women.

Percentages of CCR5 and number of CCR5 molecules on CD4+ T-cells and DR+38+CD4+ T-cells in the whole blood (A-D) and cervix (E-H) from healthy postmenopausal and premenopausal women. Horizontal lines indicate median values.

Amie L. Meditz, et al. J Acquir Immune Defic Syndr. ;59(3):221-228.
2.
FIGURE 3

FIGURE 3. From: CCR5 Expression is Elevated on Endocervical CD4+ T-Cells in Healthy Postmenopausal Women.

Age and CCR5 expression on CD4+ and activated CD4+ T-cells had a significant linear relationship in the whole blood (A, B) and cervix (C,D). Lines generated by ordinary least squares regression.

Amie L. Meditz, et al. J Acquir Immune Defic Syndr. ;59(3):221-228.
3.
FIGURE 1

FIGURE 1. From: CCR5 Expression is Elevated on Endocervical CD4+ T-Cells in Healthy Postmenopausal Women.

Representative flow cytometry plots of (A) cervical cells and (B) whole blood acquired from the lymphocyte gate of the forward-scatter versus side-scatter profile. Gates for HLA-DR, CD38, and CCR5 were set with Fluorescence Minus One (FMO) controls. CD3+CD4+ cells were defined in a dot plot then evaluated in a CD38 versus HLA-DR plot. CCR5 expression was evaluated on cells from CD3+CD4+ and CD38+HLA-DR+ quadrants using a histogram. Data were analyzed and compensated using FlowJo Software (Treestar).

Amie L. Meditz, et al. J Acquir Immune Defic Syndr. ;59(3):221-228.

Supplemental Content

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
Write to the Help Desk